BriaCell Therapeutics Corp. (TSE:BCT – Get Free Report) shot up 1.6% during mid-day trading on Monday . The company traded as high as C$4.58 and last traded at C$4.42. Approximately 5,970 shares were traded during mid-day trading, a decline of 72% from the average session volume of 20,989 shares. The stock had previously closed at C$4.35.
BriaCell Therapeutics Price Performance
The company’s 50-day moving average price is C$4.82 and its two-hundred day moving average price is C$6.45. The company has a market capitalization of C$38.45 million, a price-to-earnings ratio of -5.26 and a beta of 2.06.
About BriaCell Therapeutics
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX:BCT) is dedicated to developing novel immunotherapies to fight cancer and improve patients’ lives. Immunotherapies have become the forefront of the fight against cancer because they use the body’s immune system to destroy cancer cells, offer the potential for higher levels of safety and efficacy than chemotherapy, and may also prevent cancer recurrence.
Featured Articles
- Five stocks we like better than BriaCell Therapeutics
- The AI Boom Has a Second Act—And It’s Playing Out in Optics
- Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback?
- 5 Tech Stocks to Buy on the July Pullback
- Is OpenAI’s IPO Delay a Warning for AI Investors?
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
